Quality reporting of randomized controlled trials on SGLT2 inhibitors for heart failure: a comprehensive assessment
Crossref DOI link: https://doi.org/10.1038/s41598-024-57514-z
Published Online: 2024-03-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, YueGuang
Yang, ShunWen
Han, YuBo
Zou, GuoLiang
Wang, RuiNan
Liu, Li http://orcid.org/0000-0002-6959-6813
Text and Data Mining valid from 2024-03-21
Version of Record valid from 2024-03-21
Article History
Received: 2 January 2024
Accepted: 19 March 2024
First Online: 21 March 2024
Competing interests
: The authors declare no competing interests.